Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

Inflation had exceeded 20% in 1975; and GDP had declined in both 1973 and 1975. Unemployment had peaked in 1976 at 1.5 million.

Published on: 30 August, 2024

Public expenditure increased in 1978-79.

Published on: 30 August, 2024

Oxford was known to provide a greater quantity of clotting factors than most if not all of the other centres at the time.

Published on: 30 August, 2024

Figure for the annual consumption of Factor 8 in the UK 23 August 1999.

Published on: 30 August, 2024

Figure showing annual consumption of CFC 1976 to 1994.

Published on: 30 August, 2024

Dr Walford understood from her visit to PFC that Liberton had a substantial capacity for expansion notwithstanding substantial staffing difficulties.

Published on: 30 August, 2024

For years, it was considered that because domestic blood products were manufactured by agents of the Crown, Crown immunity rendered domestic products free of similar controls.

Published on: 30 August, 2024

Mr Wormald favoured the expansion of PFC as well as rebuilding Elstree.

Published on: 30 August, 2024

A paper by the Economic Advisors' Office concluded that the most economic option available to meet the NBS' demand for blood products was to redevelop BPL.

Published on: 30 August, 2024

A briefing paper on Blood Products Laboratory Redevelopment said that "Given that the present BPL has to be redeveloped ... it would be more expensive to build a smaller BPL (£18.6 million) and invest £4 million in PFC than to build a BPL capable of achieving self-sufficiency (£21.03 million)."

Published on: 25 October, 2024

Lord Owen described that a major motivating factor was to ensure the safety of the patient. He had in mind the dangers of hepatitis, and the increased risks of this posed by the pool sizes used by commercial companies.

Published on: 30 August, 2024

Freeze-dried fractions made from human blood were developed by Kekwick and Wolf, Soulier, Blombäck and others.

Published on: 30 August, 2024

Dr Antonio Fernández-Montoya argued in a paper that blood donation was an example of genuine altruism where the altruistic behaviour was incorporated into the self as a role.

Published on: 30 August, 2024

John Canavan wrote to the Scottish Home and Health Department to notify them of the decision to undertake a pilot testing study of anti-HCV screening.

Published on: 09 September, 2024

Dr Gunson circulated a report on Phase I of the multi-centre anti-HCV trial to Dr Rejman for the attention of the ACVSB.

Published on: 09 September, 2024

In a letter from Dr Peter Kernoff to Dr Brian Colvin, NANBH was described as a serious disease with significant long-term consequences.

Published on: 09 September, 2024

NANBH was described as already becoming "a major source of concern" in a minute regarding the establishment of an advisory group on viral hepatitis.

Published on: 09 September, 2024

In a brief circulated by Dr Metters in advance of an ACVSB meeting, he noted that the main issue for the Committee in relation to non-A non-B Hepatitis was "whether the time is right to make a decision about adopting the Chiron test".

Published on: 09 September, 2024

Dr Pickles wrote to Dr Rejman and John Canavan emphasising that they "must not delay in seeking help elsewhere in the department in refining our assessment of the cost-benefit of hepatitis C screening."

Published on: 09 September, 2024

Dr Metters asked Dr Rejman and John Canavan to provide "the best available data on the sensitivity, specificity and predictive value of the Ortho and RIBA tests".

Published on: 09 September, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2132
  • Page 2133
  • Page 2134
  • Page 2135
  • Current page 2136
  • Page 2137
  • Page 2138
  • Page 2139
  • Page 2140
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.